GLP-1 Receptor Agonist Risks: Why Stopping Treatment Matters
Comments Off on GLP-1 Receptor Agonist Risks: Why Stopping Treatment Matters
April 20, 2026
GLP-1 Clinical Relevance #47Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservationalGLP-1 Receptor AgonistSemaglutideWeight Loss…
Can CBD gummies make you depressed? – Pathologica
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthCbdDepressionDrug SafetyDosing…
Cannabis and Mental Health: Why ‘Cannabis’ and ‘d9-THC’ Are Not the Same Thing
Comments Off on Cannabis and Mental Health: Why ‘Cannabis’ and ‘d9-THC’ Are Not the Same Thing
March 30, 2026
When headlines report that 'cannabis' is detrimental for any number of things, the term is almost exclusively used as a proxy for d9-THC.